Skip to main content
Loading

Multimeric Biotherapeutics, Inc.

October 17, 2023
Franciscan C
Oncology
Multimeric Biotherapeutics, Inc. is an early-stage, founder-backed company focused on stimulating immunity against cancer and infections. Its patented FortiVac technology elicits very strong CD8+ T cell responses that can be directed against cancer and infectious agents.
Speakers
Richard Kornbluth - Multimeric Biotherapeutics, Inc.